ContractExclusive License Agreement • August 16th, 2013 • Five Prime Therapeutics Inc • Pharmaceutical preparations • California
Contract Type FiledAugust 16th, 2013 Company Industry Jurisdiction*** INDICATES MATERIAL THAT WAS OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT WAS REQUESTED. ALL SUCH OMITTED MATERIAL WAS FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.
ContractExclusive License Agreement • July 26th, 2013 • Five Prime Therapeutics Inc • Pharmaceutical preparations • California
Contract Type FiledJuly 26th, 2013 Company Industry Jurisdiction*** INDICATES MATERIAL THAT WAS OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT WAS REQUESTED. ALL SUCH OMITTED MATERIAL WAS FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.
ContractExclusive License Agreement • July 15th, 2013 • Five Prime Therapeutics Inc • Pharmaceutical preparations • California
Contract Type FiledJuly 15th, 2013 Company Industry Jurisdiction*** INDICATES MATERIAL THAT WAS OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT WAS REQUESTED. ALL SUCH OMITTED MATERIAL WAS FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.